Protective efficacy of DNA vaccines encoding outer membrane protein A and OmpK36 of Klebsiella pneumoniae in mice

Clinical and Vaccine Immunology

Volumn 18, Issue 1, 2011, Pages 82-88

  Kurupati, Prathiba ^a   Ramachandran, N P ^b   Poh, Chit Laa ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12; OPSONIN; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN A; OUTER MEMBRANE PROTEIN K36; PLASMID VECTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOGENICITY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BACTERIAL VACCINES; CELL LINE; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN G; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICE; MICE, INBRED BALB C; PORINS; TH1 CELLS; TH2 CELLS; VACCINES, DNA;

EID: 78650883952     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00275-10     Document Type: Article

References (32)

1. Albertí, S., G. Marqués, S. Camprubí, S. Merino, J. M. Tomás, F. Vivanco, and V. J. Benedí. 1993. C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins. Infect. Immun. 61:852-860.
2. Alberti, S., F. Rodriquez-Quinones, T. Schirmer, G. Rummel, J. M. Tomás, J. P. Rosenbusch, and V. J. Benedí. 1995. A porin from Klebsiella pneumoniae: sequence homology, three-dimensional model, and complement binding. Infect. Immun. 63:903-910.
3. Albertí, S., G. Marqués, S. Hernández-Allés, X. Rubires, J. M. Tomás, F. Vivanco, and V. J. Benedí. 1996. Interaction between complement subcomponent C1q and the Klebsiella pneumoniae porin OmpK36. Infect. Immun. 64:4719-4725.
4. Azad, N., and Y. Rojanasakul. 2006. Vaccine delivery - current trends and future. Curr. Drug Deliv. 3:137-146.
5. Chhibber, S., and J. Bajaj. 1995. Polysaccharide-iron-regulated cell surface protein conjugate vaccine: its role in protection against Klebsiella pneumoniae-induced lobar pneumonia. Vaccine 13:179-184.
6. Donnelly, J. J., J. B. Ulmer, J. W. Shiver, and M. A. Liu. 1997. DNA vaccines. Annu. Rev. Immunol. 15:617-648.
7. Doria-Rose, N. A., and N. L. Haigwood. 2003. DNA vaccine strategies: candidates for immune modulation and immunization regimens. Methods 31:207-216.
8. Fung, C. P., B. S. Hu, F. Y. Chang, S. C. Lee, B. I. Kuo, M. Ho, L. K. Siu, and C. Y. Liu. 2000. A 5-year study of the seroepidemiology of Klebsiella pneumoniae: high prevalence of capsular serotype K1 in Taiwan and implication for vaccine efficacy. J. Infect. Dis. 181:2075-2079.
9. Goetsch, L., A. Gonzalez, H. Pltnicky-Gilquin, et al. 2001. Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein A derived from Klebsiella pneumoniae. Infect. Immun. 69:6434-6444.
10. Jacoby, G. A., D. M. Mills, and N. Chow. 2004. Role of beta-lactamases and porins in resistance to ertapenem and other beta-lactams in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:3203-3206.
11. Je, P. W., Y. J. Cho, D. H. Ahn, S. B. Jung, N. G. Lee, H. S. Kim, K. S. Hahm, and Y. S. Kim. 1997. An outer membrane protein preparation as a vaccine against Pseudomonas aeruginosa infection. J. Microbiol. Biotechnol. 7:144-150.
12. Jeannin, P., T. Renno, L. Goetsch, I. Miconnet, et al. 2000. OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway. Nat. Immunol. 1:502-509.
13. Jeannin, P., G. Magistrelli, L. Goetsch, J. F. Haeuw, N. Thieblemont, J. Y. Bonnefoy, and Y. Delneste. 2002. Outer membrane protein A (OmpA): a new pathogen-associated molecular pattern that interacts with antigen presenting cells-impact on vaccine strategies. Vaccine 20:A23-A27. (Pubitemid 35449403)
14. + CTLs with HLA class I tetramers. J. Immunol. 165:7285-7292.
15. Koebnik, R., K. P. Locher, and P. Van Gelder. 2000. Structure and function of bacterial outer membrane proteins: barrels in a nutshell. Mol. Microbiol. 37:239-253.
16. Kuenen, J. D. M., E. E. M. van-Dijka, C. Hol, H. J. Bootsman, J. Verhoef, and H. van Dijk. 1993. Protective effect of orally-administered Klebsiella containing bacterial lysate in mice. FEMS. Immunol. Med. Microbiol. 8:69-75.
17. Kurupati, P., B. K. The, G. Kumarasinghe, and C. L. Poh. 2006. Identification of vaccine candidate antigens of an ESBL producing Klebsiella pneumoniae clinical strain by immunoproteome analysis. Proteomics 6:836-844.
18. Libon, C., J. F. Haeuw, F. Crouzet, C. Mugnier, et al. 2002. Streptococcus pneumoniae polysaccharides conjugated to the outer membrane protein A from Klebsiella pneumoniae elicit protective antibodies. Vaccine 20:2174-2180.
19. Loos, M., and F. Clas. 1987. Antibody-independent killing of gram-negative bacteria via the classical pathway of complement. Immunol. Lett. 14:203-208.
20. Luo, D., B. Ni, P. Li, W. Shi, S. Zhang, Y. Han, L. Mao, Y. He, Y. Wu, and X. Wang. 2006. Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice. Infect. Immun. 74:2734-2741.
21. Neely, A. N., A. K. Bhattacharjee, G. F. Babcock, I. A. Holder, and A. S. Cross. 2002. Differential effects of two different routes of immunization on protection against gram-negative sepsis by a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine in a burned mouse model. J. Burn Care Rehabil. 23:333-340.
22. Pautsch, A., and G. E. Schulz. 1998. Structure of the outer membrane protein A transmembrane domain. Nat. Struct. Biol. 5:1013-1017.
23. Philippon, A., and G. Arlet. 2006. Beta-lactamases of Gram negative bacteria: never-ending clockwork. Ann. Biol. Clin. (Paris) 64:37-51.
24. Podschun, R., and U. Ullmann. 1998. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev. 11:589-603.
25. Price, B. M., J. B. Legutki, D. R. Galloway, B. W. von Specht, L. B. Gilleland, H. E. Gilleland, and J. Staczek. 2002. Enhancement of the protective efficacy of an oprF DNA vaccine against Pseudomonas aeruginosa. FEMS Immunol. Med. Microbiol. 33:89-99.
26. Rauly, I., L. Goetsch, J. F. Haeuw, C. Tardieux, T. Baussant, J. Y. Bonnefoy, et al. 1999. Carrier properties of a protein derived from outer membrane protein A of Klebsiella pneumoniae. Infect. Immun. 67:5547-5551.
27. Samaha-Kfoury, J. N., and G. F. Araj. 2003. Recent developments in beta lactamases and extended spectrum beta lactamases. BMJ 327:1209-1213.
28. Senna, J. P. M., D. M. Roth, J. S. Oliveira, D. C. Machado, and D. S. Santos. 2003. Protective immune response against methicillin resistant Staphylococcus aureus in a murine model using a DNA vaccine approach. Vaccine 21:2661-2666.
29. Singh, B. R., and V. D. Sharma. 2001. Potential of Klebsiella pneumoniae cytotoxin toxoid as vaccine against klebsiellosis in rabbits and mice. Vaccine 19:4505-4510.
30. Underhill, D. M., and A. Ozinky. 2002. Toll-like receptors: key mediators of microbe detection. Curr. Opin. Immunol. 14:103-110.
31. Vivier, E., J. A. Nunes, and F. Vely. 2004. Natural killer cell signaling pathways. Science 306:1517-1519. (Pubitemid 39564941)
32. Weiser, J. N., and E. C. Gotschlich. 1991. Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1. Infect. Immun. 59:2252-2258.